It's not often you get two powerhouses to sit down and discuss their investing strategies, hottest stocks picks, earnings, the economy and more.  Investors of any age can learn from this powerful one hour conversation with TheStreet's Jim Cramer and Marc Chaikin of Chaikin Analytics. 

In the video above, they tackle Allergan (AGN)  (also in Jim Cramer's AAP portfolio).  Cramer actually looks to Chaikin for advice on the stock. 

"You can't trade them," says Chaikin, referring to not just Allergan, but all the big biotechs.

Listen to Chaikin explain why.

You can watch Cramer and Chaikin's free Webinar here.

Watch More of Cramer vs. Chaikin:

More from Video

How to Be a Tactical Investor in the Current Market

How to Be a Tactical Investor in the Current Market

Netflix Gears Up For Earnings, Canada's Ready to Legalize Cannabis

Netflix Gears Up For Earnings, Canada's Ready to Legalize Cannabis

Activist Investing Today: Why Analysts Make Good Directors

Activist Investing Today: Why Analysts Make Good Directors

Constellation Brands COO Discusses Investing in Canopy Growth

Constellation Brands COO Discusses Investing in Canopy Growth

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors